{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:00:15Z","timestamp":1770469215455,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>It is largely unknown how alcohol use affects the risk of Alzheimer`s disease (AD). Therefore, studies on the influence of alcohol use on cerebrospinal fluid (CSF) biomarkers for the earliest preclinical phase of AD are needed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was a cross-sectional cohort study. The sample (<jats:italic>n<\/jats:italic>\u2009=\u2009301) was derived from the 2014\u20132016 examinations of the Gothenburg H70 Birth Cohort Studies. The study cohort consisted of 301 70-year-old women and men, where of 246 cognitively unimpaired and 55 with mild cognitive deficits. Information on alcohol consumption (g\/week and type of alcohol) was collected and CSF amyloid-\u03b2<jats:sub>1\u221242<\/jats:sub> (A\u03b242), total-tau (T-tau), tau phosphorylated at threonine 181 (P-tau181), neurofilament light protein (NfL) and neurogranin (Ng) were measured. We tested the association between the CSF biomarkers and alcohol consumption types using correlation and linear regression, adjusting for possible confounders when necessary according to the performed sensitivity analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There were no correlations between weekly alcohol consumption and any of the CSF markers studied in the total sample of cognitively unimpaired participants (<jats:italic>n<\/jats:italic>\u2009=\u2009246). After adjustments for multiplicity with FDR, there was an association between white wine and Ng in women with CDR\u2009=\u20090 (\u03b2:0.254, CI: ( 0.069: 0.439), <jats:italic>p<\/jats:italic>\u2009=\u20090.0076, FDR\u2009=\u20090.0455). Interaction analysis between female sex and red wine intake was a significant predictor of high Ng levels (\u03b2:0.410, CI: ( 0.099: 0.721), <jats:italic>p<\/jats:italic>\u2009=\u20090.0100, FDR\u2009=\u20090.0500). There were no correlations between consumption of specific types of alcohol (spirits, white wine, red wine, fortified wine, and beer) and any of the biomarkers studied in the total sample of cognitively unimpaired participants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings indicate that higher alcohol use in older cognitively unimpaired women correlates with a biomarker of synaptic dysfunction in AD, which is an important observation in a time when alcohol use is increasing among women.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01819-2","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T09:45:40Z","timestamp":1753436740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer\u2019s disease in a population-based sample of 70-year-olds"],"prefix":"10.1186","volume":"17","author":[{"given":"Silke","family":"Kern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Skillb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Ahlner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zettergren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margda","family":"Waern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazib M","family":"Seidu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingmar","family":"Skoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"1819_CR1","unstructured":"United Nations. World Population Prospects 2019: Highlights In: Department of Economic and Social Affairs PD, editor. 2019."},{"key":"1819_CR2","unstructured":"United Nations. World Population Prospects 2019 - Special Aggregates, Online Edition. Rev. 1. In: Department of Economic and Social Affairs PD, editor. 2019."},{"key":"1819_CR3","doi-asserted-by":"crossref","unstructured":"Ahlner F, Sigstrom R, Rydberg Sterner T, Mellqvist Fassberg M, Kern S, Ostling S, et al. Birth Cohort Studies, Sweden. Alcohol Clin Exp Res. 2018;42(12):2403\u201312. Increased Alcohol Consumption Among Swedish 70-Year-Olds 1976 to 2016: Analysis of Data from The Gothenburg H70.","DOI":"10.1111\/acer.13893"},{"key":"1819_CR4","unstructured":"Organization WH. Global Status Report on Alcohol and Health. 2018: World Health Organization; 2019."},{"key":"1819_CR5","doi-asserted-by":"crossref","unstructured":"Ahlner F, Sigstr\u00f6m R, Rydberg Sterner T, Mellqvist F\u00e4ssberg M, Kern S, \u00d6stling S, et al. Alcohol Clin Exp Res. 2018;42(12):2403\u201312. Increased Alcohol Consumption Among Swedish 70-Year-Olds 1976 to 2016: Analysis of Data from The Gothenburg H70 Birth Cohort Studies, Sweden.","DOI":"10.1111\/acer.13893"},{"issue":"2","key":"1819_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/ageing\/aft136","volume":"43","author":"M Waern","year":"2014","unstructured":"Waern M, Marlow T, Morin J, Ostling S, Skoog I. Secular changes in at-risk drinking in sweden: birth cohort comparisons in 75-year-old men and women 1976\u20132006. Age Ageing. 2014;43(2):228\u201334.","journal-title":"Age Ageing"},{"issue":"1","key":"1819_CR7","first-page":"45","volume":"16","author":"LT Stelander","year":"2021","unstructured":"Stelander LT, H\u00f8ye A, Bramness JG, Selb\u00e6k G, Lunde LH, Wynn R, et al. The changing alcohol drinking patterns among older adults show that women are closing the gender gap in more frequent drinking: the Troms\u00f8 study, 1994\u20132016. Policy. 2021;16(1):45. Substance abuse treatment, prevention,.","journal-title":"Policy"},{"issue":"2","key":"1819_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/alcalc\/agn102","volume":"44","author":"C Harper","year":"2009","unstructured":"Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 2009;44(2):136\u201340.","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"1819_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","volume":"11","author":"J Rehm","year":"2019","unstructured":"Rehm J, Hasan OSM, Black SE, Shield KD, Schwarzinger M. Alcohol use and dementia: a systematic scoping review. Alzheimers Res Ther. 2019;11(1):1.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"1819_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/aje\/kwm366","volume":"167","author":"K Mehlig","year":"2008","unstructured":"Mehlig K, Skoog I, Guo X, Sch\u00fctze M, Gustafson D, Waern M, et al. Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg. Am J Epidemiol. 2008;167(6):684\u201391.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"1819_CR11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","volume":"86","author":"H Wellington","year":"2016","unstructured":"Wellington H, Paterson RW, Portelius E, T\u00f6rnqvist U, Magdalinou N, Fox NC, et al. Increased CSF neurogranin concentration is specific to alzheimer disease. Neurology. 2016;86(9):829\u201335.","journal-title":"Neurology"},{"issue":"9","key":"1819_CR12","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, Alvarez-Cerme\u00f1o JC, et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and Meta-analysis. JAMA Neurol. 2019;76(9):1035\u201348.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1819_CR13","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1038\/s41598-017-05022-8","volume":"7","author":"I Skoog","year":"2017","unstructured":"Skoog I, Borjesson-Hanson A, Kern S, Johansson L, Falk H, Sigstrom R, et al. Decreasing prevalence of dementia in 85-year olds examined 22 years apart: the influence of education and stroke. Sci Rep. 2017;7(1):6136.","journal-title":"Sci Rep"},{"key":"1819_CR14","doi-asserted-by":"crossref","unstructured":"Rydberg Sterner T, Ahlner F, Blennow K, Dahlin-Ivanoff S, Falk H, Havstam Johansson L et al. The Gothenburg H70 birth cohort study 2014-16: design, methods and study population. Eur J Epidemiol. 2018.","DOI":"10.1007\/s10654-018-0459-8"},{"issue":"2","key":"1819_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10654-018-0459-8","volume":"34","author":"T Rydberg Sterner","year":"2019","unstructured":"Rydberg Sterner T, Ahlner F, Blennow K, Dahlin-Ivanoff S, Falk H, Havstam Johansson L, et al. The Gothenburg H70 birth cohort study 2014-16: design, methods and study population. Eur J Epidemiol. 2019;34(2):191\u2013209.","journal-title":"Eur J Epidemiol"},{"key":"1819_CR16","unstructured":"NIAAA. Helping Patients Who Drink Too Much A Clinician\u2019s guide Updated 2005 Edition [Internet]. 2005."},{"issue":"3","key":"1819_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3233\/JAD-150525","volume":"49","author":"M Bjerke","year":"2016","unstructured":"Bjerke M, Kern S, Blennow K, Zetterberg H, Waern M, Borjesson-Hanson A, et al. Cerebrospinal fluid fatty Acid-Binding protein 3 is related to dementia development in a Population-Based sample of older adult women followed for 8 years. J Alzheimers Dis. 2016;49(3):733\u201341.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1819_CR18","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1038\/tp.2016.252","volume":"7","author":"K Hoglund","year":"2017","unstructured":"Hoglund K, Kern S, Zettergren A, Borjesson-Hansson A, Zetterberg H, Skoog I, et al. Preclinical amyloid pathology biomarker positivity: effects on Tau pathology and neurodegeneration. Translational Psychiatry. 2017;7(1):e995.","journal-title":"Translational Psychiatry"},{"issue":"1","key":"1819_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Sjogren M, et al. Quantification of Tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett. 2000;285(1):49\u201352.","journal-title":"Neurosci Lett"},{"issue":"3","key":"1819_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in alzheimer disease? Mol Chem Neuropathol. 1995;26(3):231\u201345.","journal-title":"Mol Chem Neuropathol"},{"issue":"6","key":"1819_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, et al. Cerebrospinal fluid beta-amyloid(1\u201342) in alzheimer disease: differences between early- and late-onset alzheimer disease and stability during the course of disease. Arch Neurol. 1999;56(6):673\u201380.","journal-title":"Arch Neurol"},{"issue":"3\u20134","key":"1819_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000449408","volume":"42","author":"C Steen Jensen","year":"2016","unstructured":"Steen Jensen C, Portelius E, Siersma V, Hogh P, Wermuth L, Blennow K, et al. Cerebrospinal fluid amyloid Beta and Tau concentrations are not modulated by 16 weeks of Moderate- to High-Intensity physical exercise in patients with alzheimer disease. Dement Geriatr Cogn Disord. 2016;42(3\u20134):146\u201358.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1819_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13195-018-0339-1","volume":"10","author":"L Gaetani","year":"2018","unstructured":"Gaetani L, Hoglund K, Parnetti L, Pujol-Calderon F, Becker B, Eusebi P, et al. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimers Res Ther. 2018;10(1):8.","journal-title":"Alzheimers Res Ther"},{"key":"1819_CR24","doi-asserted-by":"crossref","unstructured":"Portelius E, Olsson B, Hoglund K, Cullen NC, Kvartsberg H, Andreasson U et al. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. Acta Neuropathol. 2018.","DOI":"10.1007\/s00401-018-1851-x"},{"issue":"19","key":"1819_CR25","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1212\/WNL.0000000000005476","volume":"90","author":"S Kern","year":"2018","unstructured":"Kern S, Zetterberg H, Kern J, Zettergren A, Waern M, Hoglund K, et al. Prevalence of preclinical alzheimer disease: comparison of current classification systems. Neurology. 2018;90(19):e1682\u201391.","journal-title":"Neurology"},{"issue":"1","key":"1819_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00401-013-1233-3","volume":"127","author":"SM de la Monte","year":"2014","unstructured":"de la Monte SM, Kril JJ. Human alcohol-related neuropathology. Acta Neuropathol. 2014;127(1):71\u201390.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1819_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13195-015-0124-3","volume":"7","author":"H Kvartsberg","year":"2015","unstructured":"Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, et al. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from alzheimer\u2019s disease patients and healthy controls. Alzheimers Res Ther. 2015;7(1):40.","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"1819_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","volume":"72","author":"MI Kester","year":"2015","unstructured":"Kester MI, Teunissen CE, Crimmins DL, Herries EM, Ladenson JH, Scheltens P, et al. Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic alzheimer disease. JAMA Neurol. 2015;72(11):1275\u201380.","journal-title":"JAMA Neurol"},{"issue":"10","key":"1819_CR29","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.15252\/emmm.201606540","volume":"8","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Insel PS, Palmqvist S, Portelius E, Zetterberg H, Weiner M, et al. Cerebrospinal fluid tau, neurogranin, and neurofilament light in alzheimer\u2019s disease. EMBO Mol Med. 2016;8(10):1184\u201396.","journal-title":"EMBO Mol Med"},{"key":"1819_CR30","unstructured":"Michelle Mielke JAS, Kaj Blennow H, Zetterberg I, Skoog P, Vemuri MM, Machulda J, Graff-Radford DS, Knopman CR, Jack RC Jr., Petersen. Silke kern. Comparison of variables associated with CSF neurofilament, total-tau, and neurogranin. Alzheimer`s & Dementia"},{"issue":"9","key":"1819_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","volume":"86","author":"H Wellington","year":"2016","unstructured":"Wellington H, Paterson RW, Portelius E, Tornqvist U, Magdalinou N, Fox NC, et al. Increased CSF neurogranin concentration is specific to alzheimer disease. Neurology. 2016;86(9):829\u201335.","journal-title":"Neurology"},{"key":"1819_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.nutres.2024.10.002","volume":"133","author":"S Hans","year":"2025","unstructured":"Hans S, Zabetakis I, Lordan R. The potential cardioprotective bioactive compounds in fermented alcoholic beverages: mechanisms, challenges, and opportunities in beer and wine. Nutr Res. 2025;133:108\u201326.","journal-title":"Nutr Res"},{"issue":"1","key":"1819_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/ije\/28.1.77","volume":"28","author":"D Leibovici","year":"1999","unstructured":"Leibovici D, Ritchie K, Ledesert B, Touchon J. The effects of wine and tobacco consumption on cognitive performance in the elderly: a longitudinal study of relative risk. Int J Epidemiol. 1999;28(1):77\u201381.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"1819_CR34","doi-asserted-by":"publisher","first-page":"e1910319","DOI":"10.1001\/jamanetworkopen.2019.10319","volume":"2","author":"M Koch","year":"2019","unstructured":"Koch M, Fitzpatrick AL, Rapp SR, Nahin RL, Williamson JD, Lopez OL, et al. Alcohol consumption and risk of dementia and cognitive decline among older adults with or without mild cognitive impairment. JAMA Netw Open. 2019;2(9):e1910319.","journal-title":"JAMA Netw Open"},{"issue":"7465","key":"1819_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/bmj.38181.418958.BE","volume":"329","author":"T Anttila","year":"2004","unstructured":"Anttila T, Helkala EL, Viitanen M, Kareholt I, Fratiglioni L, Winblad B, et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ. 2004;329(7465):539.","journal-title":"BMJ"},{"issue":"1","key":"1819_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10654-017-0225-3","volume":"32","author":"W Xu","year":"2017","unstructured":"Xu W, Wang H, Wan Y, Tan C, Li J, Tan L, et al. Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies. Eur J Epidemiol. 2017;32(1):31\u201342.","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"1819_CR37","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0895-4356(02)00462-6","volume":"55","author":"W Huang","year":"2002","unstructured":"Huang W, Qiu C, Winblad B, Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J Clin Epidemiol. 2002;55(10):959\u201364.","journal-title":"J Clin Epidemiol"},{"key":"1819_CR38","doi-asserted-by":"crossref","unstructured":"Kern S, Syrjanen JA, Blennow K, Zetterberg H, Skoog I, Waern M et al. Association of cerebrospinal fluid neurofilament light protein with risk of mild cognitive impairment among individuals without cognitive impairment. JAMA Neurol. 2018.","DOI":"10.1001\/jamaneurol.2018.3459"},{"key":"1819_CR39","unstructured":"Michelle M, Mielke JAS, Blennow K, Zetterberg H, Vemuri P, Skoog I, Machulda MM, Kremers WK, Knopman DS, Jack C Jr, Petersen RC, Kern S. Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures,. Neurology. (3)."},{"issue":"2","key":"1819_CR40","first-page":"151","volume":"52","author":"A Venkataraman","year":"2017","unstructured":"Venkataraman A, Kalk N, Sewell G, Ritchie CW, Lingford-Hughes A. Alcohol and alzheimer\u2019s disease?-Does alcohol dependence contribute to Beta-Amyloid deposition, neuroinflammation and neurodegeneration in alzheimer\u2019s disease?? Alcohol Alcohol. 2017;52(2):151\u20138.","journal-title":"Alcohol Alcohol"},{"key":"1819_CR41","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3233\/JAD-170039","volume":"60","author":"BLR Reijs","year":"2017","unstructured":"Reijs BLR, Vos SJB, Soininen H, L\u00f6tjonen J, Koikkalainen J, Pikkarainen M, et al. Association between later life lifestyle factors and alzheimer\u2019s disease biomarkers in Non-Demented individuals: A longitudinal descriptive cohort study. J Alzheimers Dis. 2017;60:1387\u201395.","journal-title":"J Alzheimers Dis"},{"key":"1819_CR42","doi-asserted-by":"crossref","unstructured":"Andersen LSN, Simonsen AH, Vogel A, McWilliam OH, Hasselbalch SG, Frederiksen KS. Isolated elevation of 181p-tau in the cerebrospinal fluid is associated with distinct clinical features: findings from a Danish memory clinic cohort. J Alzheimers Dis. 2025:13872877251339679.","DOI":"10.1177\/13872877251339679"},{"issue":"8","key":"1819_CR43","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/gps.1351","volume":"20","author":"E Kapaki","year":"2005","unstructured":"Kapaki E, Liappas I, Paraskevas GP, Theotoka I, Rabavilas A. The diagnostic value of Tau protein, beta-amyloid (1\u201342) and their ratio for the discrimination of alcohol-related cognitive disorders from alzheimer\u2019s disease in the early stages. Int J Geriatr Psychiatry. 2005;20(8):722\u20139.","journal-title":"Int J Geriatr Psychiatry"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01819-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:09:08Z","timestamp":1757286548000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01819-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01819-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Ethical Review Board in Gothenburg. All participants gave written informed consent. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants gave written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AD, MW, UA, TS, AZ, NS and FA report no disclosure.SK has served at scientific advisory boards, speaker and \/ or as consultant for Roche, Eli Lilly, Geras Solutions, Optoceutics, Biogen, Eisai, Merry Life, Triolab, Novo Nordisk and Bioarctic, unrelated to present study content.HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program.KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD\/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Ono Pharma, Pharmatrophix, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}